Yonhap Infomax NewsOct 22
Chong Kun Dang Co. has launched Archela Inc., a new drug development subsidiary focused on three innovative pipelines—CETP inhibitor, GLP-1 agonist, and HDAC6 inhibitor—aiming to drive future growth and global expansion.
#YonhapInfomax #ChongKunDang #Archela #NewDrugDevelopment #CETPInhibitor #GLP1Agonist #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=86667
Chong Kun Dang Establishes New Drug Development Subsidiary 'Archela'—Focus on Three Key Pipelines

Chong Kun Dang Co. has launched Archela Inc., a new drug development subsidiary focused on three innovative pipelines—CETP inhibitor, GLP-1 agonist, and HDAC6 inhibitor—aiming to drive future growth and global expansion.

Yonhap Infomax
ChemistryViewsJan 6, 2025

💉How Ozempic Works: (Bio)Chemical Perspectives on Weight Loss Drugs
The science behind the hype: How do they work?, How are they made?, How safe are they?, and could they really be a panacea for the “obesity epidemic”?
https://www.chemistryviews.org/how-ozempic-works-biochemical-perspectives-on-weight-loss-drugs/

#ozempic #glp1agonist #chemistry #chemistryviews #chemviews

How Ozempic Works: (Bio)Chemical Perspectives on Weight Loss Drugs - ChemistryViews

The science behind the hype: How do they work?, How are they made?, How safe are they?, and could they really be a panacea for the “obesity epidemic”?

ChemistryViews
Kees NoomeDec 24, 2024

De medicalisering van obesitas gaat door: nu slaapapneu ook als indicatie in de VS.
#Slaapapneu
#Obesitas
#GLP1agonist
#Symptoombestrijding
#Zorgkosten
#Leefstijlkeuzes
#FDA

https://www.sciencealert.com/the-fda-just-approved-the-first-us-drug-treatment-for-sleep-apnea

Zie: https://www.thuisarts.nl/slaapapneu/ik-heb-slaap-apneu-en-wil-behandeling-kiezen onder
“Wat kun je zelf doen als je slaap-apneu hebt?”

The FDA Just Approved The First US Drug Treatment For Sleep Apnea

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans.

ScienceAlert
Howard Smith MD, AMApr 4, 2024
AI Search For New Diet Drugs: With the astronomical success of the GLP-1 agonist drugs including semaglutide and tirzepatide, shortages of these drugs are driving a search for alternatives using artificial intelligence techniques. #diet #glp1agonist #semaglutide #tirzepatide #AI
https://www.instagram.com/p/C5Woz9vLkT-/
Howard Smith MD, AMDec 9, 2023
Weight Loss Drug Helps Quash Alcohol Use Disorder:
Semaglutide squelches appetite but also significantly reduces alcohol cravings. #semaglutide #glp1agonist #alcoholusedisorder #AUD #diabetes #obesity
https://www.instagram.com/p/C0pNWSXrxEE/